NCLT Approves Apollo Hospitals' Pharmacy Business Consolidation

The National Company Law Tribunal (NCLT) has approved Apollo Hospitals Enterprise Limited's composite scheme of arrangement. Shareholder and creditor meetings are scheduled for May 16-17, 2026, to vote on the plan.

NCLT Approval Details

The NCLT officially approved Apollo Hospitals Enterprise Limited's composite scheme of arrangement on March 26, 2026. The plan involves Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited. The tribunal's order, uploaded April 2, 2026, permits the convening of necessary shareholder and creditor meetings. This approval is a critical step in the company's corporate restructuring initiative.

Strategic Importance of the Restructuring

The scheme aims to consolidate Apollo's pharmacy distribution business and establish a new, focused entity for digital health and pharmacy operations. This strategic move is intended to drive targeted growth, improve efficiency, unlock shareholder value, and enable optimal resource allocation.

Background of the Restructuring Plan

Apollo Hospitals has planned this corporate reorganisation to unlock value in its pharmacy and digital health operations. The plan involves demerging business undertakings into Apollo Healthtech Ltd (AHTL) and merging Apollo Healthco and Keimed into AHTL. The Competition Commission of India (CCI) previously approved this restructuring. The combined entity is projected to become India's largest omnichannel pharmacy and digital health platform.

Impact on Shareholders and Operations

Following the restructuring, Apollo Hospitals shareholders may gain direct shareholding in the consolidated pharmacy and digital health entity. Operations in pharmacy distribution, digital health, and related services will be streamlined under one focused business. The reorganisation aims to enhance administrative efficiency, improve supply chain transparency, and establish a dedicated vehicle for differentiated strategy and growth.

Key Risks and Conditions

The success of the scheme remains contingent on positive outcomes from the upcoming shareholder and creditor meetings. Final sanction from the NCLT is required after stakeholder consent. Additionally, all necessary statutory and regulatory approvals must be obtained for the completion of the restructuring.

Competitive Landscape

MedPlus Health Services is a key competitor, currently India's second-largest pharmacy chain. With this restructuring, Apollo Hospitals aims to establish itself as the country's largest omnichannel pharmacy distribution and digital health platform, integrating front-end and back-end operations.

Key Dates and Timelines

The NCLT order was pronounced on March 26, 2026. Shareholder meetings are scheduled for May 16, 2026, followed by creditor meetings on May 17, 2026.

Next Steps and Investor Focus

Investors will monitor the outcomes of the May 16-17 shareholder and creditor meetings. The next critical steps include securing final sanction from the NCLT after stakeholder approvals, executing the remaining parts of the composite scheme, and the eventual listing of the new entity on stock exchanges.